Synaptic Imaging Outperforms Metabolism in Diagnosing bvFTD
Publication Title: Synaptic density imaging in behavioral variant frontotemporal dementia: A comparison of 18F‐SynVesT‐1 and 18F‐FDG PET
Summary
- Question
- This study examined the ability of a novel imaging technique, 18F-SynVesT-1 PET, to measure synaptic density in patients with behavioral variant frontotemporal dementia (bvFTD) and compared it with the established 18F-FDG PET imaging method, which assesses brain glucose metabolism. The researchers aimed to determine whether synaptic density imaging offers a more sensitive and specific biomarker for bvFTD diagnosis and disease monitoring.
- Why it Matters
- Behavioral variant frontotemporal dementia (bvFTD) is a neurodegenerative disease that primarily affects social cognition and behavior. Early diagnosis is challenging due to overlapping symptoms with other conditions and limited biomarker tools. Synaptic loss is a hallmark of bvFTD and may occur decades before symptoms. Imaging synaptic density using 18F-SynVesT-1 PET provides a direct view of synaptic damage, which could improve early diagnosis, track disease progression, and inform treatment strategies. This approach has the potential to reduce diagnostic delays and enhance clinical care for bvFTD patients.
- Methods
- The researchers studied 10 patients with bvFTD and 10 age-matched healthy controls. Participants underwent PET imaging using 18F-SynVesT-1 to measure synaptic density and 18F-FDG to assess glucose metabolism. Imaging results were analyzed in primary bvFTD-related brain regions, such as the frontal cortex and anterior cingulate. Participants were also assessed for cognitive function using tools such as the Frontal Assessment Battery (FAB).
- Key Findings
- Synaptic density, as measured by 18F-SynVesT-1 PET, was significantly lower in bvFTD patients compared to healthy controls across key brain regions, including the frontal cortex, anterior cingulate, and insula. These reductions were more pronounced than the decreases in glucose metabolism detected by 18F-FDG PET. Furthermore, lower synaptic density in the frontal cortex and insula correlated with poorer executive function scores on the FAB test.
- Implications
- The findings suggest that 18F-SynVesT-1 PET is a sensitive and specific biomarker for bvFTD, potentially surpassing 18F-FDG PET in detecting early and widespread synaptic damage. This imaging method could improve diagnostic accuracy, enable earlier detection, and facilitate monitoring of disease progression and treatment efficacy. By providing a direct measure of synaptic integrity, 18F-SynVesT-1 PET may also enhance the development of targeted therapies for bvFTD.
- Next Steps
- The authors recommended further research to establish the timeline of synaptic loss in bvFTD and validate 18F-SynVesT-1 PET in larger, genetically diverse cohorts. Future studies should explore its utility in early diagnosis, tracking disease progression, and evaluating therapeutic interventions.
- Funding Information
- This research was supported by the National Institutes of Health (awards P30AG066508 and R01AG065474) and the Yale Alzheimer’s Disease Research Center. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Full Citation
Fesharaki‐Zadeh A, Cayir S, Ibrahim W, Yang Y, Gallezot J, Naganawa M, Wu Y, Toyonaga T, Sadabad F, O'Dell R, Pittman B, Nabulsi N, Strittmatter S, Carson R, Huang Y, van Dyck C, Mecca A, Matuskey D. Synaptic density imaging in behavioral variant frontotemporal dementia: A comparison of 18F‐SynVesT‐1 and 18F‐FDG PET. Alzheimer's & Dementia 2026, 22: e71283. PMID: 41954197, PMCID: PMC13063251, DOI: 10.1002/alz.71283.
This AI-assisted summary has been reviewed and approved by at least one of the study's authors to ensure it accurately reflects the research.
Authors
Arman Fesharaki-Zadeh, MD, PhD, BMath
First AuthorAssistant Professor of Psychiatry and of Neurology
David Matuskey, MD
Last AuthorAssociate Professor of Radiology and Biomedical Imaging